Publicacións en colaboración con investigadores/as de University of Parma (9)

2023

  1. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

    The Lancet, Vol. 401, Núm. 10379, pp. 821-832

  2. Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database

    eClinicalMedicine, Vol. 58

  3. Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial

    Targeted Oncology, Vol. 18, Núm. 5, pp. 639-641

2019

  1. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics

    Expert Opinion on Drug Delivery, Vol. 16, Núm. 4, pp. 397-413

2018

  1. Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-β-cyclodextrin for ocular administration

    Carbohydrate Polymers, Vol. 201, pp. 308-316

  2. Development of microemulsions of suitable viscosity for cyclosporine skin delivery

    International Journal of Pharmaceutics, Vol. 545, Núm. 1-2, pp. 197-205

  3. Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery

    Molecular Pharmaceutics, Vol. 15, Núm. 2, pp. 571-584

2017

  1. Parameters affecting the transscleral delivery of two positively charged proteins of comparable size

    International Journal of Pharmaceutics, Vol. 521, Núm. 1-2, pp. 214-221

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051